Published in Eur J Pharmacol on May 18, 1984
Prognosis in giant-cell arteritis. Br Med J (Clin Res Ed) (1981) 3.07
A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory. Am J Psychiatry (1990) 2.22
Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn. Aliment Pharmacol Ther (2007) 1.67
Dental trauma in anaesthesia. Can J Anaesth (1989) 1.51
Open trial of fluoxetine in obsessive-compulsive disorder. Am J Psychiatry (1989) 1.44
The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay. Brain Res (1981) 1.27
Phenotypic and molecular characterization of three clinical isolates of Mycobacterium interjectum. J Clin Microbiol (1997) 1.25
Prader-Willi syndrome, compulsive and ritualistic behaviours: the first population-based survey. Br J Psychiatry (2002) 1.14
Influence of isoproterenol, hydralazine and phentolamine on the renin activity of plasma and renal cortex of rats. Eur J Pharmacol (1970) 1.14
Association of postoperative delirium with raised serum levels of anticholinergic drugs. Lancet (1981) 1.13
Effect of carbenoxolone on prostaglandin synthesis and degradation. J Pharm Pharmacol (1976) 1.12
Cognitive abilities and genotype in a population-based sample of people with Prader-Willi syndrome. J Intellect Disabil Res (2004) 1.12
A study of the mechanism of the release of ATP from rat cortical astroglial cells evoked by activation of glutamate receptors. Neuroscience (1999) 1.09
Neuropsychological function in Alzheimer's disease. Pattern of impairment and rates of progression. Arch Neurol (1988) 1.09
Self-harm, capacity, and refusal of treatment: implications for emergency medical practice. A prospective observational study. Emerg Med J (2005) 1.05
American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Rehabilitation. Stroke (1997) 1.00
A four year prospective study of age-related cognitive change in adults with Down's syndrome. Psychol Med (1998) 0.99
Neosynthesis and activation of Rho by Escherichia coli cytotoxic necrotizing factor (CNF1) reverse cytopathic effects of ADP-ribosylated Rho. J Biol Chem (1999) 0.99
Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. J Clin Endocrinol Metab (2001) 0.97
Potentiation and abolition of the increase in plasma renin activity seen after hypotensive drugs in rats. Eur J Pharmacol (1972) 0.96
The mechanism of the drinking response to some hypotensive drugs: activation of the renin-angiotensin system by direct or reflex-mediated stimulation of -receptors. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.96
Fragile X mental retardation and the iduronate sulphatase locus: testing Laird's model of fra(X) inheritance. Am J Med Genet (1992) 0.96
Identical triplets: non-identical psychosis? Br J Psychiatry (1982) 0.95
Cholecystokinin octapeptide in the rat hypothalamo-neurohypophysial system. Nature (1980) 0.94
A diurnal rhythm of incorporation of L-[3H] leucine in myocardium of the rat. Recent Adv Stud Cardiac Struct Metab (1975) 0.94
Gene expression of the small GTP-binding proteins RhoA, RhoB, Rac1, and Cdc42 in adult rat brain. Brain Res Mol Brain Res (1997) 0.93
Use of a portable computer program to assist behavioral treatment in a case of obsessive compulsive disorder. J Behav Ther Exp Psychiatry (1988) 0.91
Enhanced rate of expression and biosynthesis of neuropeptide Y after kainic acid-induced seizures. J Neurochem (1991) 0.90
Prolactin cell autoantibodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry (1985) 0.89
[Inhibition by nephrectomy of drinking induced by hypotensive agents in rats]. Experientia (1971) 0.88
Effects of ruminal insufflation on renal function of conscious goats and calves. Am J Vet Res (1967) 0.87
Stimulation of receptors of gamma-aminobutyric acid modulates the release of cholecystokinin-like immunoreactivity from slices of rat neostriatum. Br J Pharmacol (1986) 0.86
The oxidation and subcellular distribution of 14 C-palmitate in experimental acute myocardial infarction. Cardiology (1971) 0.86
Effects of gabapentin on release of gamma-aminobutyric acid from slices of rat neostriatum. Arzneimittelforschung (1993) 0.86
Use of semantic context by patients with Alzheimer's disease. Psychol Aging (1986) 0.86
Deafferentation studies on the glutamic acid decarboxylase content of the supraoptic nucleus of the rat. Brain Res (1980) 0.85
Effect of isoprenaline and trimethidinium on the plasma vasopressin concentration in conscious rats. Arch Int Pharmacodyn Ther (1980) 0.85
Mental disorders and problematic behaviours in people with intellectual disability: future directions for research. J Intellect Disabil Res (1997) 0.85
Sertraline in obsessive-compulsive disorder: a double-blind comparison with placebo. Am J Psychiatry (1990) 0.84
Domesticated farm animals in medical research. Ann N Y Acad Sci (1968) 0.84
Inhibition of the transport of d-tubocurarine from blood to bile by k-strophantoside in the isolated perfused rat liver. Eur J Pharmacol (1968) 0.84
The upper airway and sleep apnoea in the Prader-Willi syndrome. Clin Otolaryngol Allied Sci (1994) 0.83
Characterization of "high-affinity" [3H]ouabain binding in the rat central nervous system. J Neurochem (1985) 0.83
Origin of the cholecystokinin-containing fibers in the rat caudatoputamen. Science (1982) 0.83
Differential expression of the small GTP-binding proteins RhoA, RhoB, Cdc42u and Cdc42b in developing rat neocortex. Brain Res Mol Brain Res (1999) 0.83
A study of the influence of different genotypes on the physical and behavioral phenotypes of children and adults ascertained clinically as having PWS. Clin Genet (2002) 0.83
Properties and the cytoskeletal control of Ca(++)-independent large conductance K+ channels in neonatal rat hippocampal neurons. J Membr Biol (1998) 0.82
Detection and characterisation of neurotransmitters, particularly peptides, in the gastrointestinal tract. Scand J Gastroenterol Suppl (1982) 0.82
Neurons are generated in confluent astroglial cultures of rat neonatal neocortex. Neuroscience (1997) 0.82
CCK-containing terminals in the hippocampus are derived from intrinsic neurons: an immunohistochemical and radioimmunological study. Brain Res (1981) 0.82
Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients. Am J Psychiatry (1989) 0.82
Influence of serotonin on water intake and the renin-angiotensin system in the rat. Arch Int Pharmacodyn Ther (1974) 0.81
Comparison of graded versus constant treadmill test protocols for quantifying intermittent claudication. Vasc Med (1997) 0.81
Fecal hemoglobin excretion in elderly patients with atrial fibrillation: combined aspirin and low-dose warfarin vs conventional warfarin therapy. Arch Intern Med (1996) 0.81
Dopamine modulates cholecystokinin release in neostriatum. Nature (1983) 0.81
[Contrast-enhancend sonography (CEUS) in pneumonia: typical patterns and clinical value - a retrospective study on n = 50 patients]. Ultraschall Med (2011) 0.81
Physiological Adjustments in Chloride Balance of the Goldfish. Science (1948) 0.80
Studies on cholecystokinin-containing neuronal pathways in rat cerebral cortex and striatum. Ann N Y Acad Sci (1985) 0.80
Cardiovascular, sympathetic, and renin-angiotensin system responses to hemorrhage in vasopressin-deficient rats. Endocrinology (1982) 0.80
Cholecystokinin-like immunoreactivity of rat medial basal hypothalamus: investigations on a possible hypophysiotropic function. Neuroendocrinology (1983) 0.80
Effect of transection of subfornical organ efferent projections on vasopressin release induced by angiotensin or isoprenaline in the rat. Brain Res (1982) 0.80
Effect of beta-casomorphins on somatostatin release in dogs. Endocrinology (1983) 0.80
The effect of naloxone on vasopressin release from rat neurohypophysis incubated in vitro. J Physiol (1983) 0.80
Modulation of post-prandial insulin release by ingested opiate-like substances in dogs. Diabetologia (1983) 0.79
Quantitative determination of prostaglandins in human gastric juice by radioimmunoassay. Clin Chim Acta (1974) 0.79
Kallikreins and kinins in inflammatory-like events in the reproductive tract. Pharmacol Res (1997) 0.79
alpha-Adrenoceptor-mediated inhibitory effect of the sympathetic nervous system on the isoprenaline-induced increase in plasma renin concentration. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.79
Loss of synaptophysin and synaptosomal-associated protein 25-kDa (SNAP-25) in elderly Down syndrome individuals. Neuropathol Appl Neurobiol (2007) 0.79
Effect of isoprenaline on the plasma concentrations of angiotensin III in rats. Clin Sci (Lond) (1979) 0.79
Effect of converting enzyme blockade on isoprenaline- and angiotensin I-induced drinking. Br J Pharmacol (1974) 0.78
VIP induces the elongation of dendrites and axons in cultured hippocampal neurons: role of microtubules. Peptides (2007) 0.78
Cholecystokinin in the central nervous system. Peptides (1981) 0.78
Glial expression of the proenkephalin gene in slice cultures of the subventricular zone. J Mol Neurosci (1998) 0.77
Evidence for cell specific regulation by PACAP38 of the proenkephalin gene expression in neocortical cells. Glia (2000) 0.77
Effects of somatostatin-14 on the in vitro release of [3H]GABA from slices of rat caudatoputamen. Neuroscience (1989) 0.77
Increased risk of Alzheimer's disease in mothers of adults with Down's syndrome. Lancet (1994) 0.77
Neuronotrophic factors released by C6 glioma cells. J Neurochem (1988) 0.77
Failure of high blood free fatty acid concentrations to provoke ventricular arrhythmias in experimental coronary artery occlusion. Br Heart J (1971) 0.77
Release of cholecystokinin-immunoreactivity into the vascular bed of the guinea-pig small intestine during peristalsis. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.77
Functional communication in Alzheimer's disease. J Speech Hear Disord (1989) 0.77
Role of the renin-angiotensin system in isoprenaline-induced vasopressin release. J Cardiovasc Pharmacol (1981) 0.77
Vasopressin release from rat medial basal hypothalamus induced in vitro by angiotensin. Eur J Pharmacol (1982) 0.77
Neocortical projections regulate the neostriatal proenkephalin gene expression. Cereb Cortex (1999) 0.76
Stimulation of GABAB receptors increases the expression of the proenkephalin gene in slice cultures of rat neocortex. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.76
Studies on the presence of angiotensin II in rat brain. J Neurochem (1982) 0.76
Development of proenkephalin gene expression in rat neocortex: a non-radioactive in situ hybridization study. Brain Res Mol Brain Res (1997) 0.76
Rundown of somatodendritic N-methyl-D-aspartate (NMDA) receptor channels in rat hippocampal neurones: evidence for a role of the small GTPase RhoA. Br J Pharmacol (1999) 0.76
The small GTPase Rac is involved in clustering of hippocampal neurons and fasciculation of their neurites. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.76
Increased brain levels of cholecystokinin octapeptide after kainic acid-induced seizures in the rat. Neurosci Lett (1986) 0.76
Concentrations of mRNAs encoding for preprosomatostatin and preprocholecystokinin are increased after kainic acid-induced seizures. Synapse (1989) 0.76
Secretogranin II is synthesized and secreted in astrocyte cultures. J Neurochem (1993) 0.76
Relationship between the IQ of people with Prader-Willi syndrome and that of their siblings: evidence for imprinted gene effects. J Intellect Disabil Res (2009) 0.76
Effects of p-chloroamphetamine on release of [3H]gamma-aminobutyric acid from slices of rat caudate-putamen. Eur J Pharmacol (1991) 0.76
Psychiatric, cognitive and behavioural outcomes following craniopharyngioma and pituitary adenoma surgery. Br J Neurosurg (2003) 0.75
Automated extraction of activity features in linear envelopes of locomotor electromyographic patterns. IEEE Trans Biomed Eng (1986) 0.75
Susceptibility to autoimmune thyroiditis in Down's syndrome is associated with the major histocompatibility class II DQA 0301 allele. Clin Endocrinol (Oxf) (1994) 0.75
Endogenous agonists may change the concentration-response curves of exogenous agonists: source of quantitative information about the endogenous tone. Biol Cybern (1987) 0.75
Influence of converting enzyme inhibition on the release of vasopressin induced by angiotensin. Br J Pharmacol (1980) 0.75